Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Prospective, Multicenter Study Assessing Functional and Psychosocial Parameters in AML Patients ≥ 60 Years Receiving Induction Chemotherapy

Sophie-Luise Mersiowsky, Gabriele Ihorst, Valerie Arnold, Michael J. Müller, Olga Grishina, Claudia Schmoor, Hartmut Bertz, Barbara Deschler-Baier, Ulrich Germing, Björn Hackanson, Michael Lübbert

Blood (2024) 144 (Supplement 1): 2864.

https://doi.org/10.1182/blood-2024-203583

Published: 2024

Journal Articles

Randomized Phase II Study of All- Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status

Blood (2021) 138 (Supplement 1): 2380.

https://doi.org/10.1182/blood-2021-146468

Published: 2021

Journal Articles

Activity of Decitabine (DAC) Combined with All-Trans Retinoic Acid (ATRA) in Oligoblastic AML: Subgroup Analysis of a Randomized 2x2 Phase II Trial

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-140664

Published: 2020

Journal Articles

In Vivo Kinetics of Early, Hypomethylating Agent-Induced Methylome and Transcriptome Changes in Primary AML Blasts: Random or Specific?

Gabriele Greve, Geoffroy Andrieux, Pascal Schlosser, Nadja Blagitko-Dorfs, Hans-Walter Lindemann, MD, Michael Heuser, MD, Andreas Neubauer, Jürgen Krauter, MD, Helmut R. Salih, MD, Gerhard Heil, Carsten Schwänen, Carsten Müller-Tidow, Arnold Ganser, MD, Hartmut Döhner, MD, Dietmar Pfeifer, Björn Hackanson, Olga Grishina, Melanie Boerries, Michael Lübbert

Blood (2018) 132 (Supplement 1): 3892.

https://doi.org/10.1182/blood-2018-99-118762

Published: 2018

Journal Articles

Validation of a Frailty Score Predicting Survival of Elderly, Non-Fit AML Patients Receiving Hypomethylating Therapy: Results of the Decider Trial

Blood (2018) 132 (Supplement 1): 720.

https://doi.org/10.1182/blood-2018-99-115974

Published: 2018

Journal Articles

Results of the Randomized Phase II Study Decider (AMLSG 14-09) Comparing Decitabine (DAC) with or without Valproic Acid (VPA) and with or without All- Trans Retinoic Acid (ATRA) Add-on in Newly Diagnosed Elderly Non-Fit AML Patients

Blood (2016) 128 (22): 589.

https://doi.org/10.1182/blood.V128.22.589.589

Published: 2016

Journal Articles

Impact of Distinct Genetic and Epigenetic Aberrations on Survival and Response in Acute Myeloid Leukemia Patients Receiving Epigenetic Therapy

Jan K. Hiller, MD, Claudia Schmoor, Verena I. Gaidzik, MD, Charlotte Schmidt-Salzmann, MD, Arzu Yalcin, PhD, Mahmoud Abdelkarim, Nadja Blagitko-Dorfs, PhD, Konstanze Döhner, MD, Lars Bullinger, MD, Justus Duyster, MD, Michael Lübbert, MD, Björn Hackanson

Blood (2016) 128 (22): 2839.

https://doi.org/10.1182/blood.V128.22.2839.2839

Published: 2016

Journal Articles

Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD

Anne-Kathrin Hechinger, Benjamin A. H. Smith, Ryan Flynn, Kathrin Hanke, Cameron McDonald-Hyman, Patricia A. Taylor, Dietmar Pfeifer, Björn Hackanson, Franziska Leonhardt, Gabriele Prinz, Heide Dierbach, Annette Schmitt-Graeff, Jiri Kovarik, Bruce R. Blazar, Robert Zeiser

Blood (2015) 125 (3): 570–580.

https://doi.org/10.1182/blood-2014-06-581793

Published: 2015

Includes: Supplemental data

Journal Articles

The Oligodendrocyte Lineage Transcription Factor 2 (OLIG2) Is Epigenetically Regulated in AML and Suppresses Leukemia Cell Growth

Arzu Yalcin, PhD, Marlon Kovarbasic, Mahmoud Abdelkarim, Gregor Klaus, Julius Wehrle, MD, Verena I. Gaidzik, MD, Heike L Pahl, PhD, Konstanze Doehner, MD, Lars Bullinger, MD PhD, Michael Lübbert, Björn Hackanson, MD

Blood (2014) 124 (21): 3540.

https://doi.org/10.1182/blood.V124.21.3540.3540

Published: 2014

Journal Articles

In Vivo Methylome Changes in Purified Peripheral Blood Blasts and T Cells of AML Patients Treated with Decitabine: Statistical Modelling of a Hypomethylation Response

Blood (2014) 124 (21): 870.

https://doi.org/10.1182/blood.V124.21.870.870

Published: 2014

Journal Articles

Long-Term Follow-up of Therapy-Related MDS and AML Patients Treated with Allogeneic Hematopoietic Cell Transplantation Reveals Substantial 10 Year Survival and Comparably Low Treatment-Related Mortality

Björn Hackanson, MD, Claudia Schmoor, PhD, Hartmut Bertz, Reinhard Marks, Ralph Wäsch, MD, Robert Zeiser, Jürgen Finke, MD

Blood (2014) 124 (21): 1264.

https://doi.org/10.1182/blood.V124.21.1264.1264

Published: 2014

Journal Articles

Tracing the development of acute myeloid leukemia in CBL syndrome

Blood (2014) 123 (12): 1883–1886.

https://doi.org/10.1182/blood-2013-10-533844

Published: 2014

Includes: Supplemental data

Journal Articles

Decitabine Response Associated Gene Expression Patterns In Acute Myeloid Leukemia (AML)

Stephan R Bohl, MD, Rainer Claus, MD, Anna Dolnik, Richard F. Schlenk, MD, Konstanze Döhner, MD, Björn Hackanson, MD, Hartmut Döhner, MD, Michael Lübbert, MD, Lars Bullinger, MD, PhD

Blood (2013) 122 (21): 3756.

https://doi.org/10.1182/blood.V122.21.3756.3756

Published: 2013

Journal Articles

TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia

Blood (2009) 113 (22): 5558–5567.

https://doi.org/10.1182/blood-2009-02-205732

Published: 2009

Includes: Supplemental data

Journal Articles

DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8 , in acute myeloid leukemia with the MLL partial tandem duplication

Susan P. Whitman, Björn Hackanson, Sandya Liyanarachchi, Shujun Liu, Laura J. Rush, Kati Maharry, Dean Margeson, Ramana Davuluri, Jing Wen, Tatiana Witte, Li Yu, Chunhui Liu, Clara D. Bloomfield, Guido Marcucci, Christoph Plass, Michael A. Caligiuri

Blood (2008) 112 (5): 2013–2016.

https://doi.org/10.1182/blood-2008-01-128595

Published: 2008

NARROW

A Prospective, Multicenter Study Assessing Functional and Psychosocial Parameters in AML Patients ≥ 60 Years Receiving Induction Chemotherapy

Randomized Phase II Study of All- Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status

Activity of Decitabine (DAC) Combined with All-Trans Retinoic Acid (ATRA) in Oligoblastic AML: Subgroup Analysis of a Randomized 2x2 Phase II Trial

In Vivo Kinetics of Early, Hypomethylating Agent-Induced Methylome and Transcriptome Changes in Primary AML Blasts: Random or Specific?

Validation of a Frailty Score Predicting Survival of Elderly, Non-Fit AML Patients Receiving Hypomethylating Therapy: Results of the Decider Trial

Results of the Randomized Phase II Study Decider (AMLSG 14-09) Comparing Decitabine (DAC) with or without Valproic Acid (VPA) and with or without All- Trans Retinoic Acid (ATRA) Add-on in Newly Diagnosed Elderly Non-Fit AML Patients

Impact of Distinct Genetic and Epigenetic Aberrations on Survival and Response in Acute Myeloid Leukemia Patients Receiving Epigenetic Therapy

Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD

The Oligodendrocyte Lineage Transcription Factor 2 (OLIG2) Is Epigenetically Regulated in AML and Suppresses Leukemia Cell Growth

In Vivo Methylome Changes in Purified Peripheral Blood Blasts and T Cells of AML Patients Treated with Decitabine: Statistical Modelling of a Hypomethylation Response

Long-Term Follow-up of Therapy-Related MDS and AML Patients Treated with Allogeneic Hematopoietic Cell Transplantation Reveals Substantial 10 Year Survival and Comparably Low Treatment-Related Mortality

Tracing the development of acute myeloid leukemia in CBL syndrome

Decitabine Response Associated Gene Expression Patterns In Acute Myeloid Leukemia (AML)

TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia

DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8 , in acute myeloid leukemia with the MLL partial tandem duplication

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only